Tellurium Compounds: Selective Inhibition of Cysteine Proteases and Model Reaction with Thiols

This publication has 24 references indexed in Scilit:

• Predominance of TH1 Response in Tumor-Bearing Mice and Cancer Patients Treated With AS 101
  JNCI Journal of the National Cancer Institute, 1996
• Design of a new selective cysteine protease inactivator and its mechanistic implications
  Bioorganic & Medicinal Chemistry Letters, 1995
• Ligand exchange processes in tetraalkoxytelluranes
  Inorganic Chemistry, 1994
• The immunomodulator AS101 administered orally as a chemoprotective and radioprotective agent
  International Journal of Immunopharmacology, 1992
• A new immunomodulating compound (AS-101) with potential therapeutic application
  Nature, 1987
• Structural chemistry of organic compounds containing selenium or tellurium
  Published by Wiley ,1986
• Structure of trans-diaquabis(ethylenediamine)nickel(II) bis(trichloroacetate), [Ni(C2H8N2)2(H2O)2](C2Cl3O2)2
  Acta Crystallographica Section C Crystal Structure Communications, 1984
• Structure of cyclic pentacoordinated molecules of main group elements
  Accounts of Chemical Research, 1979
• The synthesis and analytical use of a highly sensitive and convenient substrate of elastase
  Biochemical Medicine, 1974
• A spectrophotometric determination of trypsin and chymotrypsin
  Biochimica et Biophysica Acta, 1955